Table 6.

Based on a simulation covering a total of 180 months, impact of various dialysis strategies on the monthly per-patient costs and on the initial distribution at RRT start, the total time spent in each modality, the number of transitions and the mean lifetime for patients aged 70 years or older with diabetes

Cohort = 2096 incident patientsStatus quoRenal TR, deceased donorCombined: CAPD, APD and local facility under medical supervisionCombined: CAPD, APD and facility under medical supervisionLocal facility under medical supervisionFacility under medical supervisionLocal facility under medical supervision, transfer to Hospital-based HDFacility under medical supervision, transfer to hospital-based HDAssisted CAPD, transfer to facility under medical supervisionAssisted CAPDAssisted APD, transfer to facility under medical supervisionAssisted APD
Cost/months (euros) for 1 patient736168826917694970157051705370867222724373047314
Comparison with status quo (euros/months)−479−444−412−346−310−308−275−139−119−58−47
Initial distribution at RRT start (%)
 Hospital-based HD81.981.960.060.081.981.981.981.966.466.475.575.5
 Assisted automated PD1.61.68.08.01.61.61.61.61.61.68.08.0
 Non-assisted automated PD0.60.60.60.60.60.60.60.60.60.60.60.6
 Assisted continuous PD10.310.325.825.810.310.310.310.325.825.810.310.3
 Non-assisted continuous PD1.31.31.31.31.31.31.31.31.31.31.31.3
 HD self-care unit2.42.42.42.42.42.42.42.42.42.42.42.4
 HD home0.00.00.00.00.00.00.00.00.00.00.00.0
 Facility under medical supervision1.91.91.91.91.91.91.91.91.91.91.91.9
 Renal graft deceased donor0.00.00.00.00.00.00.00.00.00.00.00.0
 Renal graft living donor0.00.00.00.00.00.00.00.00.00.00.00.0
Distribution of the total time spent in each modality (%)
 Hospital-based HD71.464.950.950.959.359.360.760.763.263.468.268.3
 Assisted automated PD1.41.34.34.31.21.21.31.31.71.83.04.3
 Non-assisted automated PD0.70.71.11.10.60.60.60.60.90.90.91.0
 Assisted continuous PD6.76.314.214.26.26.26.26.212.915.47.17.2
 Non-assisted continuous PD1.00.91.21.20.90.90.90.91.21.31.01.0
 HD self-care unit8.87.57.37.38.38.38.38.37.88.08.48.5
 HD home0.20.20.20.20.20.20.20.20.20.20.20.2
 Facility under medical supervision8.87.219.619.622.022.020.520.511.38.110.28.5
 Renal graft deceased donor1.111.11.11.11.31.31.31.31.01.01.11.1
 Renal graft living donor0.00.00.00.00.00.00.00.00.00.00.00.0
Number of transitions entering each modality (per 2096 patients)
 Hospital-based HD202320241811181122802280224522451774173419241913
 Assisted automated PD6161214214616161617578197199
 Non-assisted automated PD272745452727272733343539
 Assisted continuous PD268267606606267267267267590590281285
 Non-assisted continuous PD424256564242424251544445
 HD self-care unit220217189189225225224224196195212211
 HD home444444443344
 Facility under medical supervision241235548548637637635635311214278230
 Renal graft deceased donor111091111131313131091010
 Renal graft living donor000000000000
Number of deaths (per 2096 patients)207920452077207720762076207520752079208020792079
Restricted mean lifetime (months)39.642.140.840.842.842.842.642.639.438.439.639.3
Cohort = 2096 incident patientsStatus quoRenal TR, deceased donorCombined: CAPD, APD and local facility under medical supervisionCombined: CAPD, APD and facility under medical supervisionLocal facility under medical supervisionFacility under medical supervisionLocal facility under medical supervision, transfer to Hospital-based HDFacility under medical supervision, transfer to hospital-based HDAssisted CAPD, transfer to facility under medical supervisionAssisted CAPDAssisted APD, transfer to facility under medical supervisionAssisted APD
Cost/months (euros) for 1 patient736168826917694970157051705370867222724373047314
Comparison with status quo (euros/months)−479−444−412−346−310−308−275−139−119−58−47
Initial distribution at RRT start (%)
 Hospital-based HD81.981.960.060.081.981.981.981.966.466.475.575.5
 Assisted automated PD1.61.68.08.01.61.61.61.61.61.68.08.0
 Non-assisted automated PD0.60.60.60.60.60.60.60.60.60.60.60.6
 Assisted continuous PD10.310.325.825.810.310.310.310.325.825.810.310.3
 Non-assisted continuous PD1.31.31.31.31.31.31.31.31.31.31.31.3
 HD self-care unit2.42.42.42.42.42.42.42.42.42.42.42.4
 HD home0.00.00.00.00.00.00.00.00.00.00.00.0
 Facility under medical supervision1.91.91.91.91.91.91.91.91.91.91.91.9
 Renal graft deceased donor0.00.00.00.00.00.00.00.00.00.00.00.0
 Renal graft living donor0.00.00.00.00.00.00.00.00.00.00.00.0
Distribution of the total time spent in each modality (%)
 Hospital-based HD71.464.950.950.959.359.360.760.763.263.468.268.3
 Assisted automated PD1.41.34.34.31.21.21.31.31.71.83.04.3
 Non-assisted automated PD0.70.71.11.10.60.60.60.60.90.90.91.0
 Assisted continuous PD6.76.314.214.26.26.26.26.212.915.47.17.2
 Non-assisted continuous PD1.00.91.21.20.90.90.90.91.21.31.01.0
 HD self-care unit8.87.57.37.38.38.38.38.37.88.08.48.5
 HD home0.20.20.20.20.20.20.20.20.20.20.20.2
 Facility under medical supervision8.87.219.619.622.022.020.520.511.38.110.28.5
 Renal graft deceased donor1.111.11.11.11.31.31.31.31.01.01.11.1
 Renal graft living donor0.00.00.00.00.00.00.00.00.00.00.00.0
Number of transitions entering each modality (per 2096 patients)
 Hospital-based HD202320241811181122802280224522451774173419241913
 Assisted automated PD6161214214616161617578197199
 Non-assisted automated PD272745452727272733343539
 Assisted continuous PD268267606606267267267267590590281285
 Non-assisted continuous PD424256564242424251544445
 HD self-care unit220217189189225225224224196195212211
 HD home444444443344
 Facility under medical supervision241235548548637637635635311214278230
 Renal graft deceased donor111091111131313131091010
 Renal graft living donor000000000000
Number of deaths (per 2096 patients)207920452077207720762076207520752079208020792079
Restricted mean lifetime (months)39.642.140.840.842.842.842.642.639.438.439.639.3

Shaded values correspond to the modalities of treatment impacted by the given strategy. Bold values correspond to hospital-based HD.

Table 6.

Based on a simulation covering a total of 180 months, impact of various dialysis strategies on the monthly per-patient costs and on the initial distribution at RRT start, the total time spent in each modality, the number of transitions and the mean lifetime for patients aged 70 years or older with diabetes

Cohort = 2096 incident patientsStatus quoRenal TR, deceased donorCombined: CAPD, APD and local facility under medical supervisionCombined: CAPD, APD and facility under medical supervisionLocal facility under medical supervisionFacility under medical supervisionLocal facility under medical supervision, transfer to Hospital-based HDFacility under medical supervision, transfer to hospital-based HDAssisted CAPD, transfer to facility under medical supervisionAssisted CAPDAssisted APD, transfer to facility under medical supervisionAssisted APD
Cost/months (euros) for 1 patient736168826917694970157051705370867222724373047314
Comparison with status quo (euros/months)−479−444−412−346−310−308−275−139−119−58−47
Initial distribution at RRT start (%)
 Hospital-based HD81.981.960.060.081.981.981.981.966.466.475.575.5
 Assisted automated PD1.61.68.08.01.61.61.61.61.61.68.08.0
 Non-assisted automated PD0.60.60.60.60.60.60.60.60.60.60.60.6
 Assisted continuous PD10.310.325.825.810.310.310.310.325.825.810.310.3
 Non-assisted continuous PD1.31.31.31.31.31.31.31.31.31.31.31.3
 HD self-care unit2.42.42.42.42.42.42.42.42.42.42.42.4
 HD home0.00.00.00.00.00.00.00.00.00.00.00.0
 Facility under medical supervision1.91.91.91.91.91.91.91.91.91.91.91.9
 Renal graft deceased donor0.00.00.00.00.00.00.00.00.00.00.00.0
 Renal graft living donor0.00.00.00.00.00.00.00.00.00.00.00.0
Distribution of the total time spent in each modality (%)
 Hospital-based HD71.464.950.950.959.359.360.760.763.263.468.268.3
 Assisted automated PD1.41.34.34.31.21.21.31.31.71.83.04.3
 Non-assisted automated PD0.70.71.11.10.60.60.60.60.90.90.91.0
 Assisted continuous PD6.76.314.214.26.26.26.26.212.915.47.17.2
 Non-assisted continuous PD1.00.91.21.20.90.90.90.91.21.31.01.0
 HD self-care unit8.87.57.37.38.38.38.38.37.88.08.48.5
 HD home0.20.20.20.20.20.20.20.20.20.20.20.2
 Facility under medical supervision8.87.219.619.622.022.020.520.511.38.110.28.5
 Renal graft deceased donor1.111.11.11.11.31.31.31.31.01.01.11.1
 Renal graft living donor0.00.00.00.00.00.00.00.00.00.00.00.0
Number of transitions entering each modality (per 2096 patients)
 Hospital-based HD202320241811181122802280224522451774173419241913
 Assisted automated PD6161214214616161617578197199
 Non-assisted automated PD272745452727272733343539
 Assisted continuous PD268267606606267267267267590590281285
 Non-assisted continuous PD424256564242424251544445
 HD self-care unit220217189189225225224224196195212211
 HD home444444443344
 Facility under medical supervision241235548548637637635635311214278230
 Renal graft deceased donor111091111131313131091010
 Renal graft living donor000000000000
Number of deaths (per 2096 patients)207920452077207720762076207520752079208020792079
Restricted mean lifetime (months)39.642.140.840.842.842.842.642.639.438.439.639.3
Cohort = 2096 incident patientsStatus quoRenal TR, deceased donorCombined: CAPD, APD and local facility under medical supervisionCombined: CAPD, APD and facility under medical supervisionLocal facility under medical supervisionFacility under medical supervisionLocal facility under medical supervision, transfer to Hospital-based HDFacility under medical supervision, transfer to hospital-based HDAssisted CAPD, transfer to facility under medical supervisionAssisted CAPDAssisted APD, transfer to facility under medical supervisionAssisted APD
Cost/months (euros) for 1 patient736168826917694970157051705370867222724373047314
Comparison with status quo (euros/months)−479−444−412−346−310−308−275−139−119−58−47
Initial distribution at RRT start (%)
 Hospital-based HD81.981.960.060.081.981.981.981.966.466.475.575.5
 Assisted automated PD1.61.68.08.01.61.61.61.61.61.68.08.0
 Non-assisted automated PD0.60.60.60.60.60.60.60.60.60.60.60.6
 Assisted continuous PD10.310.325.825.810.310.310.310.325.825.810.310.3
 Non-assisted continuous PD1.31.31.31.31.31.31.31.31.31.31.31.3
 HD self-care unit2.42.42.42.42.42.42.42.42.42.42.42.4
 HD home0.00.00.00.00.00.00.00.00.00.00.00.0
 Facility under medical supervision1.91.91.91.91.91.91.91.91.91.91.91.9
 Renal graft deceased donor0.00.00.00.00.00.00.00.00.00.00.00.0
 Renal graft living donor0.00.00.00.00.00.00.00.00.00.00.00.0
Distribution of the total time spent in each modality (%)
 Hospital-based HD71.464.950.950.959.359.360.760.763.263.468.268.3
 Assisted automated PD1.41.34.34.31.21.21.31.31.71.83.04.3
 Non-assisted automated PD0.70.71.11.10.60.60.60.60.90.90.91.0
 Assisted continuous PD6.76.314.214.26.26.26.26.212.915.47.17.2
 Non-assisted continuous PD1.00.91.21.20.90.90.90.91.21.31.01.0
 HD self-care unit8.87.57.37.38.38.38.38.37.88.08.48.5
 HD home0.20.20.20.20.20.20.20.20.20.20.20.2
 Facility under medical supervision8.87.219.619.622.022.020.520.511.38.110.28.5
 Renal graft deceased donor1.111.11.11.11.31.31.31.31.01.01.11.1
 Renal graft living donor0.00.00.00.00.00.00.00.00.00.00.00.0
Number of transitions entering each modality (per 2096 patients)
 Hospital-based HD202320241811181122802280224522451774173419241913
 Assisted automated PD6161214214616161617578197199
 Non-assisted automated PD272745452727272733343539
 Assisted continuous PD268267606606267267267267590590281285
 Non-assisted continuous PD424256564242424251544445
 HD self-care unit220217189189225225224224196195212211
 HD home444444443344
 Facility under medical supervision241235548548637637635635311214278230
 Renal graft deceased donor111091111131313131091010
 Renal graft living donor000000000000
Number of deaths (per 2096 patients)207920452077207720762076207520752079208020792079
Restricted mean lifetime (months)39.642.140.840.842.842.842.642.639.438.439.639.3

Shaded values correspond to the modalities of treatment impacted by the given strategy. Bold values correspond to hospital-based HD.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close